Da Silva et al. found that DPP4 inhibitors regulated CXCL10-mediated T-lymphocyte and NK cell migration in mouse melanoma- and hepatocellular carcinoma-transplanted tumor models [19]. This evidence concerns the gene CXCL10 and neoplasm.